RYTM

113.0603.20%
YM

Yann Mazabraud

Executive VP & Head of International

Mr. Yann Mazabraud serves as Executive Vice President and Head of International at Rhythm Pharmaceuticals, Inc. since October 5, 2020. Mr. Mazabraud served as Chief Commercial Officer and Head of International at Trevi Therapeutics, Inc. since November 2017 until October 3, 2020. Prior to that, he held several leadership positions at Sanofi Genzyme, including as U.S. General Manager and North America Head, Rare Diseases from January 2016 to October 2017 and Vice President and Head of Latin America from March 2014 to December 2015 and as North America Head, Rare Diseases. He also served as a member of the Sanofi Genzyme Executive Leadership Team. While at Genzyme and Sanofi Genzyme, he led and managed several product launches for rare genetic diseases in Europe, Latin America and the United States across multiple areas including genetics, pediatrics, nephrology, neurology and endocrinology. Mr. Mazabraud was responsible for Genzyme’s business and the patients in Latin America. Mr. Mazabraud provided leadership and direction for more than 500 employees in 15 locations in Latin America. Mr. Mazabraud served as Senior Business Unit Director of Rare Diseases, Latin America. He served as Business Unit Director of Renal-Cardiovascular Division at Clinical Science Associate, Rare Diseases, France. He holds M.A. in Management from Ecole Supérieure de Commerce de la Rochelle.

Positions